Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Jump-Start Your Search For Promising Trade Ideas With Barchart’s Top Stock Pick. FREE 30 Day Trial

Stocks | Futures | Watchlist | More
or

Nanostring Tech (NSTG)

Nanostring Tech (NSTG)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 680,207
  • Shares Outstanding, K 46,494
  • Annual Sales, $ 145,090 K
  • Annual Income, $ -115,250 K
  • 60-Month Beta 1.92
  • Price/Sales 4.97
  • Price/Cash Flow N/A
  • Price/Book 6.40
Trade NSTG with:

Options Overview Details

View History
  • Implied Volatility 113.90% ( +18.06%)
  • Historical Volatility 87.53%
  • IV Percentile 99%
  • IV Rank 94.27%
  • IV High 118.01% on 05/11/22
  • IV Low 46.30% on 09/02/21
  • Put/Call Vol Ratio 13.17
  • Today's Volume 170
  • Volume Avg (30-Day) 1,197
  • Put/Call OI Ratio 1.19
  • Today's Open Interest 39,861
  • Open Int (30-Day) 28,156

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 5 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/22
See More
  • Average Estimate -0.46
  • Number of Estimates 3
  • High Estimate -0.36
  • Low Estimate -0.56
  • Prior Year -0.69
  • Growth Rate Est. (year over year) +33.33%

Price Performance

See More
Period Period Low Period High Performance
1-Month
11.12 +29.77%
on 07/26/22
18.51 -22.04%
on 08/11/22
+2.86 (+24.72%)
since 07/18/22
3-Month
11.12 +29.77%
on 07/26/22
18.51 -22.04%
on 08/11/22
-0.52 (-3.48%)
since 05/18/22
52-Week
11.12 +29.77%
on 07/26/22
62.34 -76.85%
on 09/10/21
-36.45 (-71.64%)
since 08/18/21

Most Recent Stories

More News
Study Using NanoString’s GeoMx Digital Spatial Profiler Featured on the Cover of Nature Genetics

NanoString Technologies, Inc. (NASDAQ: NSTG), a leading provider of life science tools for discovery and translational research, today announced a peer-reviewed paper published in Nature Genetics using...

NSTG : 14.43 (-1.37%)
Wall Street Analysts Think NanoString (NSTG) Could Surge 116%: Read This Before Placing a Bet

The consensus price target hints at an 116.4% upside potential for NanoString (NSTG). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate...

NSTG : 14.43 (-1.37%)
NanoString Technologies (NSTG) Reports Q2 Loss, Lags Revenue Estimates

NanoString (NSTG) delivered earnings and revenue surprises of -37.10% and 0.57%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

NSTG : 14.43 (-1.37%)
TGTX : 7.31 (-1.62%)
NanoString Technologies Releases Operating Results for Second Quarter of 2022

NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today reported financial results for the second quarter ended June 30, 2022....

NSTG : 14.43 (-1.37%)
NanoString to Webcast Presentations from Two Upcoming Healthcare Conferences

NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today announced that company management is scheduled to webcast presentations...

NSTG : 14.43 (-1.37%)
Earnings Preview: NanoString Technologies (NSTG) Q2 Earnings Expected to Decline

NanoString (NSTG) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

NSTG : 14.43 (-1.37%)
NVST : 39.56 (+0.03%)
Wall Street Analysts See a 172% Upside in NanoString (NSTG): Can the Stock Really Move This High?

The consensus price target hints at a 171.7% upside potential for NanoString (NSTG). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate...

NSTG : 14.43 (-1.37%)
NanoString (NSTG) Surges 5.1%: Is This an Indication of Further Gains?

NanoString (NSTG) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in...

NSTG : 14.43 (-1.37%)
EYE : 36.92 (+0.90%)
DermTech Appoints Two New Board Members

DermTech, Inc. (NASDAQ: DMTK) (“DermTech” or the “Company”), a leader in precision dermatology enabled by a non-invasive skin genomics platform, today announced the appointment of Kirk D. Malloy,...

DMTK : 5.95 (-1.00%)
NSTG : 14.43 (-1.37%)
NanoString to Release Second Quarter 2022 Operating Results and Host Conference Call on Thursday, August 4, 2022

NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today announced that the Company will report second quarter 2022 operating...

NSTG : 14.43 (-1.37%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 40% Sell with a Weakening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

NanoString Technologies, Inc. is engaged in the development, manufacture and sale of life science tools. It provides nCounter Analysis System which supports research and development of clinical applications from basic discovery to the development of future molecular diagnostic tests on a single platform....

See More

Key Turning Points

3rd Resistance Point 15.45
2nd Resistance Point 15.06
1st Resistance Point 14.75
Last Price 14.43
1st Support Level 14.05
2nd Support Level 13.66
3rd Support Level 13.35

See More

52-Week High 62.34
Fibonacci 61.8% 42.78
Fibonacci 50% 36.73
Fibonacci 38.2% 30.69
Last Price 14.43
52-Week Low 11.12

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar